166 related articles for article (PubMed ID: 12094148)
1. The role of apoptosis in thyroid disease.
Tsatsoulis A
Minerva Med; 2002 Jun; 93(3):169-80. PubMed ID: 12094148
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis in autoimmune and non-autoimmune thyroid disease.
Ludgate M; Jasani B
J Pathol; 1997 Jun; 182(2):123-4. PubMed ID: 9274519
[TBL] [Abstract][Full Text] [Related]
3. Thyrocyte targets and effectors of autoimmunity: a role for death receptors?
Hammond LJ; Palazzo FF; Shattock M; Goode AW; Mirakian R
Thyroid; 2001 Oct; 11(10):919-27. PubMed ID: 11716038
[TBL] [Abstract][Full Text] [Related]
4. Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis.
Bossowski A; Czarnocka B; Bardadin K; Stasiak-Barmuta A; Urban M; Dadan J; Ratomski K; Bossowska A
Autoimmunity; 2008 Mar; 41(2):163-73. PubMed ID: 18324486
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune thyroid disease: new models of cell death in autoimmunity.
Stassi G; De Maria R
Nat Rev Immunol; 2002 Mar; 2(3):195-204. PubMed ID: 11913070
[TBL] [Abstract][Full Text] [Related]
6. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex.
Izeradjene K; Douglas L; Delaney AB; Houghton JA
Cancer Res; 2004 Nov; 64(21):8036-44. PubMed ID: 15520213
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the expression of Fas, FasL and Bcl-2 in the pathogenesis of autoimmune thyroid disorders.
Chen S; Fazle Akbar SM; Zhen Z; Luo Y; Deng L; Huang H; Chen L; Li W
Cell Mol Immunol; 2004 Jun; 1(3):224-8. PubMed ID: 16219172
[TBL] [Abstract][Full Text] [Related]
8. Messengers of cell death: apoptotic signaling in health and disease.
Rossi D; Gaidano G
Haematologica; 2003 Feb; 88(2):212-8. PubMed ID: 12604411
[TBL] [Abstract][Full Text] [Related]
9. Analysis of apoptosis in relation to tissue destruction associated with Hashimoto's autoimmune thyroiditis.
Hammond LJ; Lowdell MW; Cerrano PG; Goode AW; Bottazzo GF; Mirakian R
J Pathol; 1997 Jun; 182(2):138-44. PubMed ID: 9274522
[TBL] [Abstract][Full Text] [Related]
10. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP
Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649
[TBL] [Abstract][Full Text] [Related]
11. Involvement of tumor necrosis factor-alpha receptor 1 and tumor necrosis factor-related apoptosis-inducing ligand-(TRAIL) receptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantation.
Tashiro H; Itamoto T; Ohdan H; Arihiro K; Tateaki Y; Nakahara H; Ochi M; Hino H; Mizunuma K; Hara H; Tokita D; Onoe T; Ishiyama K; Mitsuta H; Sugino K; Asahara T
Transpl Int; 2004 Nov; 17(10):626-33. PubMed ID: 15502938
[TBL] [Abstract][Full Text] [Related]
12. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
Lawrence CP; Chow SC
FEBS Lett; 2005 Nov; 579(28):6465-72. PubMed ID: 16289096
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
Zhang L; Fang B
Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease.
Giordano C; Richiusa P; Bagnasco M; Pizzolanti G; Di Blasi F; Sbriglia MS; Mattina A; Pesce G; Montagna P; Capone F; Misiano G; Scorsone A; Pugliese A; Galluzzo A
Thyroid; 2001 Mar; 11(3):233-44. PubMed ID: 11327614
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD40 and apoptosis related molecules in autoimmune thyroid diseases.
Kie JH; Cho MS; Yang WI
Yonsei Med J; 2001 Oct; 42(5):488-96. PubMed ID: 11675676
[TBL] [Abstract][Full Text] [Related]
16. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
17. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma.
Tafuku S; Matsuda T; Kawakami H; Tomita M; Yagita H; Mori N
Eur J Haematol; 2006 Jan; 76(1):64-74. PubMed ID: 16343273
[TBL] [Abstract][Full Text] [Related]
18. Oral cancer cell lines can use multiple ligands, including Fas-L, TRAIL and TNF-alpha, to induce apoptosis in Jurkat T cells: possible mechanisms for immune escape by head and neck cancers.
Kassouf N; Thornhill MH
Oral Oncol; 2008 Jul; 44(7):672-82. PubMed ID: 17996489
[TBL] [Abstract][Full Text] [Related]
19. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
20. Protein-based therapeutic approaches targeting death receptors.
French LE; Tschopp J
Cell Death Differ; 2003 Jan; 10(1):117-23. PubMed ID: 12655300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
